Please assess the completion status of the following clinical trial:

Trial Title: Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* age 18 years or more~* acute myeloid leukemia or myelosysplasia undergoing induction remission or consolidation therapy~* allogeneic stem cell transplant recipients~Exclusion Criteria:~* prior invasive mould infection

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- preemptive (Type: NO_INTERVENTION): Patients with persistent fever and neutropenia despite appropriate antibacterial therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).